Home ASCO 2026: Kelun-Biotech / Merck TROP2 ADC Combo Reshapes First-Line NSCLC

ASCO 2026: Kelun-Biotech / Merck TROP2 ADC Combo Reshapes First-Line NSCLC

May 22, 2026 15:44 CST Updated 17:02
Kelun-Biotech

Innovative Drug Developer